<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2013-10-11 07:24:04Lipid storage disorders Lysosomal Acid Lipase Deficiency Wolman disease Cholesteryl ester storage disease Sanfilippo syndrome Lysosomal storage disease Hunter syndrome Enzyme replacement therapy Mucopolysaccharidosis Health Medicine Rare diseases |
|
SYNAGEVA BIOPHARMA™ HIGHLIGHTS DATA AT THE NASPGHAN MEETING LEXINGTON, Mass., October 11, [removed]Synageva BioPharma Corp. (Synageva) (NASDAQ:GEVA), a biopharmaceutical company developing therapeutic products for rare